NHS Mid and South Essex Tier 2 Community Gynaecology and Urology Services

  • NHS Mid and South Essex Integrated Care Board

F14: Notice for changes or additional information

Notice identifier: 2025/S 000-008477

Procurement identifier (OCID): ocds-h6vhtk-04e505 (view related notices)

Published 10 March 2025, 11:16am



Section one: Contracting authority/entity

one.1) Name and addresses

NHS Mid and South Essex Integrated Care Board

Phoenix House, Christopher Martin Road

Basildon, Essex

SS14 3HG

Contact

NHS Mid

Email

esther.pettigrew@attain.co.uk

Telephone

+44 2034356590

Country

United Kingdom

Region code

UKH3 - Essex

National registration number

8QE

Internet address(es)

Main address

https://www.midandsouthessex.ics.nhs.uk


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NHS Mid and South Essex Tier 2 Community Gynaecology and Urology Services

Reference number

ACE-0801-2025-MSE

two.1.2) Main CPV code

  • 85110000 - Hospital and related services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to Mayflower Healthcare Alliance Limited to deliver Tier 2 Gynaecology and Urology to the patients within Mid and South Essex's geographical footprint. The contract will be for six months from 01st April 2025 - 30th September 2025, with an option for a further six months to 31st March 2026 . The aggregate contract value is forecasted at £796,263.00

The provider is an existing provider, who is currently satisfying the requirements of the existing contract. The provider has been assessed against the criteria specified for this DAP C process:

Quality & Innovation 20%.

Value 20%.

Integration, Collaboration & Service Sustainability 20%,

Access Health Inequalities and Choice 20%;

Social Value 20%.

Key criteria were specified, and assessment against each criterion was assessed based on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2025/S 000-006231


Section seven. Changes

seven.1.2) Text to be corrected in the original notice

Section number

Section VI

Instead of
Text

Section VI: Complementary information

VI.3) Additional information

Value of the field:

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Tuesday 6th March 2025. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR.

Written Representation should be sent to: Kevin.Edwards@Attain.co.uk

The Decision Maker for this award was Mid and South Essex ICB Executive Board based on the value and term of the contract.

There were no conflicts of interest declared by individuals making the decision.

All five key criteria were utilised in determining the suitability and continuation of the provider and weighting was distributed equally across the criteria as all were felt to be as important.

The provider is satisfying the original contract and will likely satisfy the proposed contract, based on the DAP C assessment to a sufficient standard.

Read
Text

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.. This contract has now been formally awarded using Direct Award Process C(DAP C).

There were no Conflicts of Interest identified amongst the decision making committee and individuals completing the assessment. All conflicts are managed using the ICB COI processes along with the NHSE COI guidance and PSR Regulation 21 and guidance.

The contract will be for six months from 01st April 2025 - 30th September 2025, with an option for a further six months to 31st March 2026.

The aggregate contract value is forecasted at £796,263.00.